Data suggest potential therapeutic role for nomacopan in exacerbations in severe lung conditions such as COPD and COVID pneumonia NEW YORK and LONDON, …
Akari Therapeutics Announces New Data with Nomacopan from its Surface of the Eye Program
Nomacopan eyedrops reduced inflammation more than both standard treatments cyclosporin and the steroid dexamethasone in a model of allergic eye diseaseBuilding …
Akari Therapeutics to Present at the Cantor Virtual Global Healthcare Conference
NEW YORK and LONDON, September 22, 2021 – Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biopharmaceutical company focused on innovative therapeutics to …
Akari Therapeutics to Present at the H.C. Wainwright Global Investment Conference
NEW YORK and LONDON, September 7, 2021 – Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biopharmaceutical company focused on innovative therapeutics to …
Akari Therapeutics to Present at the H.C. Wainwright Global Investment Conference
NEW YORK and LONDON, September 7, 2021 – Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biopharmaceutical company focused on innovative therapeutics to …
